MDxHealth (NASDAQ:MDXH) Shares Up 0.5% – Should You Buy?

MDxHealth SA (NASDAQ:MDXH) traded up 0.5% during mid-day trading on Thursday . The company traded as high as $2.01 and last traded at $2.01. 76,024 shares changed hands during trading, an increase of 16% from the average session volume of 65,621 shares. The stock had previously closed at $2.00.

MDxHealth Price Performance

The firm’s 50-day simple moving average is $2.47 and its 200 day simple moving average is $2.61.

MDxHealth (NASDAQ:MDXH) last posted its quarterly earnings data on Wednesday, August 21st. The company reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.05). MDxHealth had a negative net margin of 50.54% and a negative return on equity of 987.86%. The firm had revenue of $22.16 million during the quarter, compared to analysts’ expectations of $20.66 million. On average, equities analysts forecast that MDxHealth SA will post -1.16 EPS for the current year.

MDxHealth Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.